Megan Ji

Associate
Full contact info

Experience

AN2 Therapeutics – $79 Million IPO

March 25, 2022

Cooley advised AN2 Therapeutics on its $79 million initial public offering of 4,600,000 shares of common stock at a price to the public of $15.00 per share. AN2 is a clinical-stage biopharmaceutical company developing treatments for rare, chronic and serious infectious diseases with high unmet needs. Partner Josh Seidenfeld, associate Anitha Anne and Sally Kay of counsel led the Cooley team.

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Anitha Anne
Associate, San Francisco
Sally Kay
Of Counsel, Palo Alto
Megan Ji
Associate, Seattle
Kristina Krasnikova
Associate, Palo Alto
Barbara Mirza
Partner, Los Angeles Santa Monica
Alexander Ellebracht
Associate, Palo Alto

Related Practices & Industries

Rani Therapeutics – $73 Million IPO

July 31, 2021

Cooley advised Rani Therapeutics on its $73.3 million initial public offering of 6,666,667 shares of Class A common stock. Rani Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol RANI, is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics. Partners Josh Seidenfeld, Mark Weeks, John McKenna and Charlie Kim led the Cooley team.

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Mark Weeks
Partner, Palo Alto
John McKenna
Partner, Palo Alto
Charlie Kim
Partner, San Diego
Marina Remennik
Special Counsel, Palo Alto
Alexa M. Smith (Ekman)
Associate, San Diego
Megan Ji
Associate, Seattle
Rachel Lydon
Associate, San Diego
Karen Gustavson
Associate, Seattle

Related Practices & Industries

Dynavax Technologies – $200 Million Convertible Notes Offering

May 11, 2021

Cooley advised Dynavax Technologies on its offering of $200 million principal amount of 2.50% convertible senior notes due 2026. Dynavax Technologies, whose securities trade on the Nasdaq Capital Market under the symbol DVAX, is a biopharmaceutical company focused on developing and commercializing novel vaccines. Partners Steve Przesmicki, Mischi a Marca and Jason Savich le the Cooley team.

Related contacts

Steve Przesmicki
Partner, San Diego
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Marina Remennik
Special Counsel, Palo Alto
Megan Ji
Associate, Seattle
Ron Metzger
Paralegal Specialist, San Francisco
Ellie Guadiana
Partner, Los Angeles Santa Monica
Matt Kong
Associate, San Francisco
Xueqing Li
Associate, San Francisco
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries